CBX7 regulates metastasis of basal-like breast cancer through Twist1/EphA2 pathway

被引:9
作者
Dai, Tao [1 ]
Liu, Yiqi [2 ]
Cao, Renxian [3 ]
Cao, Jingying [4 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Urol,Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Hengyang 421001, Hunan, Peoples R China
[3] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Inst Clin Med, Hengyang 421001, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Hosp 3, Dept Med Clin Lab, Changsha 410013, Hunan, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2022年 / 24卷
基金
中国国家自然科学基金;
关键词
Basal-like breast cancer; CBX7; EphA2; Metastasis; Twist1; TUMOR-METASTASIS; GROWTH; TARGET; EPHA2;
D O I
10.1016/j.tranon.2022.101468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Basal-like breast cancer (BLBC) is an important subtype of breast cancer. Twist1 is a key transcription factor in BLBC metastasis, which serves a key role in tumorigenesis. The potential mechanism of Twist1 in BLBC remains to be elucidated. Here, we explored the role and molecular mechanism of Twist1 in BLBC. Methods: The levels of CBX7, Twist1 and EphA2 in BLBC tissues and cells were determined by Western blot. ChIP and dual-luciferase reporter assays confirmed the interaction between CBX7, Twist1 and EphA2 promoter. The cellular functions were analyzed by CCK-8, colony formation, wound healing and Transwell assays. Expression of EMT related proteins was analyzed by Western blot. IHC measured the expression of CBX7, Twist1 and EphA2 in tumor tissues. Results: CBX7 was down-regulated in BLBC tissues and cells, whereas Twist1 and EphA2 were up-regulated. Twist1 silencing inhibited the cell migration, invasion and cancer metastasis of BLBC through targeting EphA2 and regulating EphA2 expression. Additionally, CBX7 blocked the binding of Twist1 to EphA2 promoter and inhibited EphA2 expression and suppressed BLBC growth and metastasis via Twist1/EphA2 axis. Conclusion: CBX7 suppresses BLBC growth and metastasis through Twist1/EphA2 pathway. Our study may provide evidence and new therapeutic targets for the comprehensive treatment of BLBC.
引用
收藏
页数:12
相关论文
共 25 条
[1]   Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1 [J].
Cao, Jingying ;
Wang, Xin ;
Dai, Tao ;
Wu, Yuanzhong ;
Zhang, Meifang ;
Cao, Renxian ;
Zhang, Ruhua ;
Wang, Gang ;
Jiang, Rou ;
Zhou, Binhua P. ;
Shi, Jian ;
Kang, Tiebang .
THERANOSTICS, 2018, 8 (10) :2739-2751
[2]   Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis [J].
Casas, Esmeralda ;
Kim, Jihoon ;
Bendesky, Andres ;
Ohno-Machado, Lucila ;
Wolfe, Cecily J. ;
Yang, Jing .
CANCER RESEARCH, 2011, 71 (01) :245-254
[3]   PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway [J].
Chen, Jinhuang ;
Yuan, Wenzheng ;
Wu, Liang ;
Tang, Qiang ;
Xia, Qinghua ;
Ji, Jintong ;
Liu, Zhengyi ;
Ma, Zhijun ;
Zhou, Zili ;
Cheng, Yifeng ;
Shu, Xiaogang .
ONCOTARGET, 2017, 8 (06) :9961-9973
[4]   Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex [J].
Fattet, Laurent ;
Jung, Hae-Yun ;
Matsumoto, Mike W. ;
Aubol, Brandon E. ;
Kumar, Aditya ;
Adams, Joseph A. ;
Chen, Albert C. ;
Sah, Robert L. ;
Engler, Adam J. ;
Pasquale, Elena B. ;
Yang, Jing .
DEVELOPMENTAL CELL, 2020, 54 (03) :302-+
[5]  
Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]
[6]   Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer [J].
Iqbal, Mohammad Askandar ;
Siddiqui, Shumaila ;
Ur Rehman, Asad ;
Siddiqui, Farid Ahmad ;
Singh, Prithvi ;
Kumar, Bhupender ;
Saluja, Daman .
MOLECULAR ONCOLOGY, 2021, 15 (05) :1450-1465
[7]   5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation [J].
Itou, Junji ;
Tsukihara, Hiroshi ;
Nukatsuka, Mamoru ;
Toi, Masakazu ;
Takechi, Teiji .
CANCER MEDICINE, 2018, 7 (02) :463-470
[8]   Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome [J].
Jang, Min Hye ;
Kim, Hyun Jeong ;
Kim, Eun Joo ;
Chung, Yul Ri ;
Park, So Yeon .
HUMAN PATHOLOGY, 2015, 46 (09) :1267-1274
[9]   CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential [J].
Li, Juanni ;
Alvero, Ayesha B. ;
Nuti, Sudhakar ;
Tedja, Roslyn ;
Roberts, Cai M. ;
Pitruzzello, Mary ;
Li, Yimin ;
Xiao, Qing ;
Zhang, Sai ;
Gan, Yaqi ;
Wu, Xiaoying ;
Mor, Gil ;
Yin, Gang .
ONCOGENE, 2020, 39 (20) :3965-3979
[10]   Prognostic values of distinct CBX family members in breast cancer [J].
Liang, Yuan-Ke ;
Lin, Hao-Yu ;
Chen, Chun-Fa ;
Zeng, De .
ONCOTARGET, 2017, 8 (54) :92375-92387